基础医学与临床 ›› 2014, Vol. 34 ›› Issue (1): 130-133.

• 短篇综述 • 上一篇    下一篇

NOX4是肺纤维化的潜在治疗靶点

孙宝迪,聂时南   

  1. 南京军区南京总医院
  • 收稿日期:2013-01-07 修回日期:2013-04-28 出版日期:2014-01-05 发布日期:2013-12-26
  • 通讯作者: 聂时南 E-mail:shn_nie@sina.com
  • 基金资助:
    南京军区南京总医院青年基金课题

NOX4 is a potential therapeutic target against development of pulmonary fibrosis

  • Received:2013-01-07 Revised:2013-04-28 Online:2014-01-05 Published:2013-12-26

摘要: 肺纤维是一种高致死率的难治性疾病,TGF-β1可激活并上调NOX4 mRNA的表达,继而诱导机体产生大量ROS,而ROS可进一步激活Smad,参与介导TGF-β1/Smad信号通路,最终促使肺纤维化的发生。而通过各种技术手段阻断NOX4基因表达可干扰TGF-β1/Smad信号通路从而阻断肺纤维化,所以NOX4可能是肺纤维化进程中最具有前景的治疗靶点。

关键词: 急性肺损伤, 还原型烟酰胺腺嘌呤二核苷酸磷酸氧化酶4, 肺纤维化, 氧自由基, 转化生长因子-β1

Abstract: Pulmonary fibrosis is a refractory disease with high mortality. The expression of NOX4 mRNA can be activated and increased by TGF-beta1 which could induce the production of a large number of ROS. ROS could further activate Smad which involved in mediating the signaling pathway of TGF-β1/Smad leading to the occurrence of pulmonary fibrosis. Blocking the expression of NOX4 gene through varieties of technologies would disturb the signaling pathway of TGF-β1/Smad which may block the progress of pulmonary fibrosis. Therefore NOX4 may be the most promising therapeutic target in the process of pulmonary fibrosis.

Key words: acute lung injury, NOX4, pulmonary fibrosis , ROS, TGF-β1

中图分类号: